Skip to main content
. Author manuscript; available in PMC: 2017 Dec 27.
Published in final edited form as: Eur Cell Mater. 2017 Dec 5;34:341–364. doi: 10.22203/eCM.v034a21

Fig. 6.

Fig. 6

Relative mRNA levels from pooled medial tibial and femoral cartilage in the ACLT knee normalised to contralateral knee for each treatment condition. Data shown as mean ± 95 % CI. * shows significant difference (p < 0.05, exact p-values shown in Table 4) compared to contralateral knee within each treatment group. n = 9–10 joints in each group.